GEHCV Stock Ownership Activity

GE HEALTHCARE INC-W/I 13F holders

2 value investing gurus have made changes to the GE HEALTHCARE INC-W/I (GEHCV) position according to the gurus' latest SEC quarterly report(s). The number of GEHCV shares has been increased by 1, decreased by 1 super investor(s).

Which gurus or hedge funds are buying GEHCV now?

According to the latest SEC filing(s) GE HEALTHCARE INC-W/I (GEHCV) has been bought by John Armitage - Egerton Capital (added shares +149.02%).

To see more about who is investing in GE HEALTHCARE INC-W/I (GEHCV), please go to the GEHCV ownership page.

2024 Q1 (2 results)
John Armitage
+149.02%
+5,210,342
+4.58%
7.65%
Harry Burn
-27.44%
-278,207
-0.79%
2.09%
Current price: $56.00 38.40% AVG reported price*: $90.91
2023 Q4 (3 results)
John Armitage
buy
+3,496,512
+2.93%
2.93%
Nelson Peltz
+0.00%
+3
+0.00%
1.48%
Harry Burn
-16.14%
-195,210
-0.52%
2.72%
Current price: $56.00 27.57% AVG reported price*: $77.32
2023 Q3 (3 results)
Harry Burn
+21.78%
+216,249
+0.56%
3.15%
V. D. Dodge, E. M. Cox
-0.32%
-34,131
-0.00%
0.80%
Ravenel Boykin Curry IV
-9.50%
-2,022
-0.00%
0.01%
Current price: $56.00 17.70% AVG reported price*: $68.04
2023 Q2 (4 results)
V. D. Dodge, E. M. Cox
+9.09%
+895,231
+0.08%
0.96%
Harry Burn
-1.21%
-12,166
-0.04%
2.97%
Ravenel Boykin Curry IV
-7.10%
-1,627
-0.00%
0.01%
Christopher Bloomstran
-22.83%
-1,355
-0.03%
0.09%
Current price: $56.00 31.07% AVG reported price*: $81.24
2023 Q1 (5 results)
Harry Burn
buy
+1,005,085
+3.10%
3.10%
Nelson Peltz
buy
+1,342,830
+2.94%
2.94%
V. D. Dodge, E. M. Cox
buy
+9,846,866
+0.92%
0.92%
Ravenel Boykin Curry IV
buy
+22,915
+0.01%
0.01%
Christopher Bloomstran
buy
+5,936
+0.12%
0.12%
Current price: $56.00 31.73% AVG reported price*: $82.03
17 of 17

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.